THE METOCLOPRAMIDE FOR AVOIDING PNEUMONIA AFTER STROKE (MAPS-2) TRIAL: A SINGLE-BLIND RCT OF METOCLOPRAMIDE FOR THE PREVENTION OF PNEUMONIA IN PATIENTS WITH DYSPHAGIA AFTER STROKE
(2021)
Presentation / Conference
Roffe, C., Bath, P., Warusevitane, A., Smith, C., Dixit, A., Sprigg, N., …Ogollah, R. (2021, November). THE METOCLOPRAMIDE FOR AVOIDING PNEUMONIA AFTER STROKE (MAPS-2) TRIAL: A SINGLE-BLIND RCT OF METOCLOPRAMIDE FOR THE PREVENTION OF PNEUMONIA IN PATIENTS WITH DYSPHAGIA AFTER STROKE. Presented at UK Stroke Forum 2021, Virtual
All Outputs (3)
MoTaStim-Foot, a Randomized, Single-Blinded, Mixed-Methods, Feasibility Study Exploring Sensory Stimulation of the Foot and Ankle Early Poststroke (2018)
Presentation / Conference
Aries, A. M., Pomeroy, V. M., Sim, J., Read, S., & Hunter, S. M. (2018, November). MoTaStim-Foot, a Randomized, Single-Blinded, Mixed-Methods, Feasibility Study Exploring Sensory Stimulation of the Foot and Ankle Early Poststroke. Presented at 2018 American Society of Neurorehabilitation Annual Meeting, San Diego, CA. United StatesIntroduction: It is not known whether increasing somatosensation of the foot could improve walking recovery after stroke. This study was undertaken to investigate the feasibility of conducting a future randomized controlled trial (RCT) to determine w... Read More about MoTaStim-Foot, a Randomized, Single-Blinded, Mixed-Methods, Feasibility Study Exploring Sensory Stimulation of the Foot and Ankle Early Poststroke.
EPIDEMIOLOGY144. IDENTIFICATION OF CHRONIC WIDESPREAD PAIN IN PRIMARY CARE (2017)
Presentation / Conference
Mansfield, K. E., Sim, J., & Jordan, K. P. (2017, April). EPIDEMIOLOGY144. IDENTIFICATION OF CHRONIC WIDESPREAD PAIN IN PRIMARY CARE. Poster presented at Rheumatology 2017